Ossium Health
Building the world's first bone marrow bank to treat blood cancers.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | $52.0m Valuation: $315m | Series C | |
| Total Funding | 000k | ||
Related Content
Ossium Health is a pioneering biotechnology company focused on developing advanced cell therapies to improve human health, vitality, and longevity. Operating in the healthcare and life sciences sector, Ossium Health collaborates with healthcare providers, life science companies, and organ procurement organizations to create and deploy innovative treatments. The company specializes in utilizing stem cells sourced from deceased donors to address diseases of the blood and immune systems, organ transplant rejection, and orthopedic conditions. Ossium Health's business model revolves around research and development, clinical trials, and partnerships to bring their therapies to market. Revenue is generated through collaborations, licensing agreements, and sales of their proprietary cell therapy products.
Keywords: cell therapy, stem cells, deceased donors, blood diseases, immune system, organ transplant, orthopedics, biotechnology, healthcare, life sciences.